ClinicalTrials.gg

TargetBeta

CDK4

cyclin dependent kinase 4 · also PSK-J3 · Cyclin dependent kinases

12 programs in company-led studies act on CDK4, from 11 companies: 4 in phase 3, 3 approved with new studies. Each with where its target was read from.

Programs

Furthest phase first. A target read by rule is marked rule (8 of them); the others are the company’s own words or a reading by Claude, each quoted on the program’s page.

ProgramCompanyFurthest phaseStudiesAlso acts onRead from
abemaciclibruleEli Lillyphase 44914 runningCDK6NCIt
palbociclibrulePfizerphase 4364 runningCCND1, CDK6ChEMBL
trilaciclibrulePharmacosmosphase 4143 runningCDK6NCIt
atirmociclibPfizerphase 31710 running–the company's pipeline
HRS-6209Jiangsu HengRui Medicinephase 377 running–the company's pipeline
culmerciclibSino Biopharmaceuticalphase 3115 runningCDK2, CDK6the company's pipeline
CDK4 Inhibitor BGB-43395ruleBeOne Medicinesphase 342 running–NCIt
narazaciclibruleHangzhou Hanx Biopharmaceuticalsphase 243 runningCDK6, NUAK1NCIt
vustanaciclibRegor Pharmaceuticalsphase 233 runningCDK2, CDK6a judged reading
CG-7321ruleChengdu Cynogen Bio-pharmaceutical Tech.phase 111 runningCDK2the studies' text
nkt5097 cdk2ruleNiKang Therapeuticsphase 111 runningCDK2the studies' text
TSL2109ruleChina Resources Pharmaceutical Groupphase 111 running–the studies' text

Also acted on by the same programs

Conditions their studies are in

Primary completions ahead

Each program’s next study to reach its primary completion, by the sponsor’s estimate.

What this can’t show

  • Only programs whose target has been read: most early programs are named only by a code and their companies do not say what they act on.
  • A target read by rule can be wrong; each program’s page quotes the words it was read from.
  • “Acts on” does not say how: an agonist and an antagonist of the same receptor are listed together (avexitide blocks the GLP-1 receptor that semaglutide activates).
  • Programs in company-led studies on ClinicalTrials.gov with a study in the last two years; academic studies and other registries are not counted here.